Lung Cancer Clinical Trials in Boston

Showing 641-641 of 641 trials

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

NCT00290017

This Phase 3 study will compare the efficacy of talabostat plus pemetrexed to pemetrexed plus placebo in patients with Stage IIIB/IV NSCLC who have failed a platinum-based chemotherapy regimen.

Carcinoma, Non-Small-Cell LungLung CancerNeoplasms, Lung+1 more

Point Therapeutics400 participantsStarted Feb 2006

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Hot Springs, Arkansas, United States +98 more locations

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Lung Cancer Trials in Other Cities

Other Conditions in Boston